Repositioning itraconazole for amelioration of bleomycin-induced pulmonary fibrosis: Targeting HMGB1/TLR4 Axis, NLRP3 inflammasome/NF-κB signaling, and autophagy
Abeer Elkhoely et al, 2023, Life Sciences CrossRef
Itraconazole Inhibits the Growth of Cutaneous Squamous Cell Carcinoma by Targeting HMGCS1/ACSL4 Axis
Congcong Xu et al, 2022, Frontiers in Pharmacology CrossRef
Single-cell transcriptional signature-based drug repurposing and in vitro evaluation in colorectal cancer
Roohallah Mahdi-Esferizi et al, 2024, BMC Cancer CrossRef
The OSR9 Regimen: A New Augmentation Strategy for Osteosarcoma Treatment Using Nine Older Drugs from General Medicine to Inhibit Growth Drive
Richard E. Kast, 2023, International Journal of Molecular Sciences CrossRef
Itraconazole inhibits tumor growth via CEBPB‐mediated glycolysis in colorectal cancer
Yong Zhang et al, 2024, Cancer Science CrossRef
Synthetic Activators of Autophagy
Ekaterina A. Guseva et al, 2024, Biochemistry (Moscow) CrossRef
Beyond cyclopamine: Targeting Hedgehog signaling for cancer intervention
Beena Thazhackavayal Baby et al, 2024, Archives of Biochemistry and Biophysics CrossRef
Cancer Metabolism as a Therapeutic Target and Review of Interventions
Matthew T. J. Halma et al, 2023, Nutrients CrossRef
Repurposed itraconazole for use in the treatment of malignancies as a promising therapeutic strategy
Chun-Lan Li et al, 2022, Biomedicine & Pharmacotherapy CrossRef
Non-self glycan structures as possible modulators of cancer progression: would polysaccharides from Cryptococcus spp. impact this phenomenon?
Israel Diniz-Lima et al, 2023, Brazilian Journal of Microbiology CrossRef
MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen
Richard E. Kast et al, 2022, Cancers CrossRef
Current trends and future prospects of drug repositioning in gastrointestinal oncology
Nayeralsadat Fatemi et al, 2024, Frontiers in Pharmacology CrossRef